Author: Kalup Alexander
The California Legislature on Monday unveiled a bill imposing a new tax on health insurance plans that would prevent a massive $1.1 billion hole in the state budget.
More than 425,000 Californians have signed up on the state’s health insurance exchange — with nearly 100,000 rushing to enroll in the last four days before the 2016 open enrollment period ended Jan. 31, officials said Thursday.
Parker Conrad, CEO and co-founder of once high-flying Zenefits, has resigned amid a scandal involving allegations that employees sold insurance without holding proper licenses to do so.
Embattled drug entrepreneur Martin Shkreli — who vigorously defended his decision to hike the price of a life-saving drug from $13.50 to $750 — suddenly went silent Thursday at a Congressional committee, smirking and grinning instead of answering questions.
Stung by losses under the federal health law, major insurers are seeking to sharply limit how policies are sold to individuals in ways that consumer advocates say seem to discriminate against the sickest and could hold down future enrollment.
President Barack Obama will propose tailoring the controversial "Cadillac tax" on expensive private health insurance plans to reflect regional differences when he releases his 2017 budget plan next week, a senior White House adviser said in an article released on Wednesday.
A new hospital model is coming to the Las Vegas Valley. Dignity Health, which runs three St. Rose Dominican campuses in Henderson and southwest Las Vegas, plans four smaller neighborhood hospitals across the Las Vegas Valley in the next two years.
With four days left in the sign-up period, Nevada's health insurance exchange is closing in on 80,000 customers.
In response to recent infections and deaths from tainted medical scopes, U.S. lawmakers are wrestling with how to keep other dangerous devices from harming patients.
After Martin Shkreli raised the price of anti-parasitic drug Daraprim more than 50-foldto $750 a pill last year, he said he wasn’t alone in taking big price hikes. As it turns out, the former drug executive was right. A survey of about 3,000 brand-name prescription drugs found that prices more than doubled for 60 and at least quadrupled for 20 since December 2014.